MUSCAT – In an official announcement, the Ministry said the move follows the integration of the medical device and supplies establishment registration service with the national release system, a step aimed at strengthening regulatory oversight and ensuring the safety and quality of products in the market.
The directive, issued by the Directorate General of Pharmaceutical Affairs and Drug Control, applies to all owners and managers of companies and institutions in the sector. Firms have been instructed to expedite registration processes, comply fully with approved regulatory requirements before requesting shipment releases, and ensure alignment with applicable laws.
The six-month compliance window began from the issuance of Circular No. 15/2026 on February 16, after which unregistered establishments will no longer be able to release shipments, the Ministry warned.
Read More
- African Bank of Oman launched in Luanda; HH Sayyid Theyazin hails it as a new milestone in Oman–Africa relations
- Oman authorities seize 140 packages of expired veterinary medicines in North Sharqiyah
- Oman invests RO 1.9 billion in food security, targets 400 new projects in 2026
- Consumer Protection Authority reports over 500 market violations; Muscat records highest
- Oman’s Spring of Roses 2026 in Jabal Akhdar generates jobs, boosts tourism economy
